Granite FO LLC’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.5K Hold
400
– – 0.01% 90
2026
Q2
$17.1K Hold
400
– – 0.01% 88
2026
Q1
$25.1K Hold
400
– – 0.01% 85
2025
Q4
$38.1K Sell
400
-2,000
-83% -$196K 0.02% 85
2025
Q3
$234K Hold
2,400
– – 0.13% 45
2025
Q2
$258K Hold
2,400
– – 0.15% 43
2025
Q1
$242K Hold
2,400
– – 0.14% 42
2024
Q4
$214K Hold
2,400
– – 0.12% 45
2024
Q3
$201K Buy
+2,400
New +$189K 0.11% 51
2024
Q2
– Sell
-2,400
Closed -$191K – 79
2024
Q1
$191K Hold
2,400
– – 0.11% 54
2023
Q4
$139K Hold
2,400
– – 0.09% 63
2023
Q3
$127K Hold
2,400
– – 0.09% 63
2023
Q2
$130K Sell
2,400
-4,600
-66% -$240K 0.09% 69
2023
Q1
$365K Buy
+7,000
New +$330K 0.23% 50

Other funds holding BSX

Granite FO LLC's BSX Position: Q3 2026 in Review

Granite FO LLC held its Boston Scientific (BSX) position steady in Q3 2026 at 400 shares worth $17.5K. The position accounts for 0.01% of the portfolio, ranked #90.

Granite FO LLC first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. The position peaked at $365K in Q1 2023. 558 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Granite FO LLC held 400 shares of Boston Scientific worth $17.5K as of Q3 2026.
  • Granite FO LLC left its Boston Scientific share count unchanged in Q3 2026.
  • Boston Scientific made up 0.01% of Granite FO LLC's portfolio in Q3 2026, its #90 holding.
  • Granite FO LLC first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
  • Granite FO LLC's Boston Scientific position peaked at $365K in Q1 2023.
  • 558 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Granite FO LLC's 13F filing for Q3 2026, filed 14 Oct 2026.